相关实验视频
Updated: Jul 15, 2025

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
29.9K
由于ABCD1载体缺乏,导致胆固醇恒温的改变
Agnieszka Buda1, Sonja Forss-Petter1, Rong Hua2,3
1Department of Pathobiology of the Nervous System, Center for Brain Research, Medical University of Vienna, 1090 Vienna, Austria.
Biomolecules
|September 28, 2023
概括
由于ABCD1基因突变,X链 adrenoleukodystrophy (X-ALD) 破坏胆固醇代谢,导致非常长链脂肪酸的积累. 这项研究揭示了X-ALD中改变的胆固醇水平和类固醇生成,这表明了新的治疗点.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- 与X相关的上腺核衰竭 (X-ALD) 是最常见的过氧体疾病,由ABCD1突变引起.
- 缺少ABCD1导致非常长链脂肪酸 (VLCFA) 积累,影响高胆固醇循环的特定细胞类型.
研究的目的:
- 研究ABCD1缺陷对X-ALD患者纤维细胞和ABCd1缺陷小鼠中枢神经系统组织中的胆固醇代谢的影响.
- 探索X-ALD.中VLCFA积累和胆固醇平衡之间的关系.
主要方法:
- 对人类X-ALD纤维细胞和小鼠中枢神经系统组织的脂质组分析.
- 参与胆固醇代谢的关键酶和载体的基因表达分析 (SOAT1,NCEH1,ABCA1,Apoe).
- 评估类固醇生成和过氧体-脂质滴滴共定位.
主要成果:
- 在X-ALD模型中观察到增加的胆固醇度,特别是CE(26:0) 和CE(26:1).
- 在X-ALD细胞和组织中,SOAT1,NCEH1,ABCA1和Apoe表达的升级,以及脂肪滴形成的增加.
- 在X-ALD纤维细胞中扩大孕激素诱导的皮质醇释放表明改变了类固醇生成.
结论:
- 在X-ALD中,ABCD1缺陷显著影响胆固醇平衡和类固醇生成.
- 研究结果将VLCFA积累与胆固醇代谢障碍联系起来.
- 建议在X-ALD管理中针对VLCFA和胆固醇水平的潜在治疗策略.
关键词:
在ABCD1中,ABCD1是ABCD1.在ABCD1 KO小鼠中.在VLCFAFA中使用VLCFA.与X结合的 adrenoleukodystrophy与X结合的 adrenoleukodystrophy是指X结合的 adrenoleukodystrophy与X结合的 adrenoleukodystrophy是指X结合的 adrenoleukodystrophy与X结合的 adrenoleukodystrophy是指X结合的 adrenoleukodystrophy与X结合的 adrenoleukodystrophy是指X结合的 adrenoleukodystrophy与X结合的 adrenoleukodystrophy是指X结合的 adrenoleukodystrophy与X结合的 adrenoleukodystrophy.胆固醇 Ester 是一种胆固醇.皮质醇是一种皮质醇.脂质滴滴滴滴滴滴滴滴滴滴滴滴滴脂质新陈代谢 脂质新陈代谢脂质组的类型是什么相关概念视频
Cholesterol: Significance and Regulation
572
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
572
Hepatic Drug Clearance: Role of Transporters
78
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
78
Carrier-Mediated Transport
460
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
460
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
ABC Transporters: Exporter
4.4K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.4K
Factors Influencing Drug Absorption: Disease States and Pharmacology
551
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
551

